Adagene Inc. (ADAG) Financials

ADAG Assets vs Liabilities

DateAssetsLiabilities
2023-06-30 135.3 million 52.5 million
2023-03-31 152.4 million 69.3 million
2022-12-31 152.4 million 69.3 million
2022-09-30 152.4 million 69.3 million

ADAG Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-06-30 2.0 million 2.0 million
2023-03-31 15.7 million 2.4 million
2022-12-31 ? ?
2022-09-30 2.4 million 2.4 million

ADAG Net Income

No data available :(

ADAG Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-06-30 128.8 million - 300290
2023-03-31 143.8 million - -
2022-12-31 143.8 million - 205817
2022-09-30 143.8 million - -

ADAG Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-06-30 43.7 million
2023-03-31 43.3 million
2022-12-31 54.1 million
2022-09-30 43.0 million

ADAG Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-06-30 - 21.3 million 2.2 million 2.2 million
2023-03-31 787528 36.0 million 2.5 million 2.5 million
2022-12-31 - - - -
2022-09-30 - 18.1 million 2.5 million 17364

ADAG Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-06-30 17.3 million 8.6 million
2023-03-31 5.3 million 2.7 million
2022-12-31 - -
2022-09-30 2.7 million -

ADAG

Price: $2.41

52 week price:
1.10
4.38

Earnings Per Share: -0.86 USD

P/E Ratio: -4.13

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 47600

Market Capitalization: 125.7 million

Links: